PHASTAR recapitalized by Charterhouse Capital Partners

Dec. 2020

Client: PHASTAR is a rapidly growing, global specialist biometrics clinical research organization ("CRO") offering statistical consulting, clinical trial reporting, data management, and data science services through both dedicated functional service provider (“FSP”) and expert in-house project management (“Project-Based”) delivery models to pharmaceutical sponsors around the world

Role: Edgemont Partners acted as exclusive financial advisor to PHASTAR in its recapitalization by Charterhouse

Location: London, UK

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

phastar logo

recapitalized by

charterhouse logo
Get In Touch